We present the case of a 31-year-old woman with recent refractory bipolar disorder who developed a malignant syndrome preceded by catatonic motor features. This resistant case of lethal catatonia responded selectively to high-dose olanzapine treatment. The case illustrates the need to consider lethal catatonia in apparent cases of neuroleptic malignant syndrome that do not respond to conventional treatment with dantrolene and bromocriptine.
Boyarsky B K, Fuller M, Early T (1999) Malignant catatonia-induced respiratory failure with response to ECT. J ECT15: 232–236
2.
Blumer D (1997) Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings. Compr Psychiatry38: 193–201
3.
Castillo E, Rubin R T, Holsboer-Trachsler E (1989) Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry146: 324–328
4.
Conley R R, Tamminga C A, Bartko J J, Richardson C, Peszke M, Lingle J et al. (1998) Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatry155: 914–920
5.
Kleft E V, DeHert M, Heytens L, Demey H E, Ghenens J (1991) Management of lethal catatonia with dantrolene sodium. Crit Care Med19: 1449–1451
6.
Mann S C, Caroff S N, Bleier H R, Welz W K R, Kling M A, Hayashida M (1986) Lethal catatonia. Am J Psychiatry143: 1374–1381
7.
Nolen W A, Zwann W A (1990) Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report.Acta Psychiatr Scand82: 90–92
8.
Rosebush P I, Hildebrand A M, Furlong B G, Mazurek M F (1990) Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation and response to lorazepam. J Clin Psychiatry51: 357–363
9.
Sheitman B B, Lindgren J C, Early J, Sved M (1997) High dose olanzapine in treatment-refractory schizophrenia. Am J Psychiatry154: 1626-1626.
10.
Tohen M, Sanger T M, McElroy S L, Tollefson G D, Changappa K N, Daniel D G et al. (1999) Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry156: 702–709
